Related Experiment Video
Updated: Jun 27, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from
Chenxu Yu1, Jacob Hale, Kenneth Ritchie
1Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN, USA.
Abstract:
Binding of Epidermal growth factor (EGF) to epidermal growth factor receptor (EGFR) in two types of cancer cells (HeLa; 5 x 10(4) EGFR/cell) and MDA-MB-468; 2 x 10(6) EGFR/cell) was studied using Total Internal Reflectance Fluorescence (TIRF) microscopy at single molecule precision. Mathematical modeling of the binding kinetics revealed that cells respond differently to the same concentration of EGF depending on the expression level of EGFR. Compared to Hela, MDA-MB-468 cells show; (a) higher number of pre-formed dimers, (b) improved EGF-EGFR interaction at lower ligand concentrations, and (c) shorter time-lapse between first and second EGF binding to the dimer. Treatment with a pharmacological inhibitor of EGFR, AG1478, produced strikingly different binding kinetics where the extent of pre-formed EGFR dimers increased substantially. Thus, single molecule approaches produce novel, quantitative information on signaling mechanisms of significant biological importance. Surface kinetics could also serve as surrogate markers to predict biological outcome of signaling pathways.
Insights
Cancer cells respond differently to Epidermal Growth Factor (EGF) based on Epidermal Growth Factor Receptor (EGFR) levels. Single-molecule imaging reveals distinct binding kinetics and dimer formation, impacting cell signaling pathways.
Area of Science:
- Cell Biology
- Biophysics
- Cancer Research
Background:
- Epidermal Growth Factor Receptor (EGFR) is a key target in cancer therapy.
- Understanding Epidermal Growth Factor (EGF) binding kinetics is crucial for cancer treatment strategies.
- Cancer cells exhibit varying EGFR expression levels, influencing cellular response.
Purpose of the Study:
- To investigate the single-molecule binding kinetics of EGF to EGFR in cancer cells with different EGFR expression levels.
- To elucidate how EGFR density affects EGF-EGFR interactions and dimer formation.
- To assess the impact of EGFR inhibition on binding dynamics.
Main Methods:
- Utilized Total Internal Reflectance Fluorescence (TIRF) microscopy for single-molecule precision.
- Employed mathematical modeling to analyze binding kinetics.
- Studied EGF-EGFR interactions in HeLa and MDA-MB-468 cancer cell lines.
- Investigated the effect of the EGFR inhibitor AG1478.
Main Results:
- Cells with higher EGFR expression (MDA-MB-468) showed more pre-formed dimers and enhanced EGF binding at lower concentrations compared to HeLa cells.
- A shorter time-lapse between sequential EGF binding to dimers was observed in high-EGFR cells.
- EGFR inhibition with AG1478 significantly increased the formation of pre-formed EGFR dimers.
Conclusions:
- EGFR expression levels critically modulate EGF-EGFR binding kinetics and dimer formation in cancer cells.
- Single-molecule analysis provides novel quantitative insights into cancer cell signaling mechanisms.
- Surface binding kinetics may serve as predictive biomarkers for signaling pathway outcomes.
More Related Videos
10:43Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
Published on: November 6, 2019
06:51Confocal Microscopy Reveals Cell Surface Receptor Aggregation Through Image Correlation Spectroscopy
Published on: August 2, 2018
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal